These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1194114

  • 1. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA, Renshaw HW, Vaughn HW, Stauber EH, Frank FW.
    J Am Vet Med Assoc; 1975 Dec 15; 167(12):1080-3. PubMed ID: 1194114
    [Abstract] [Full Text] [Related]

  • 2. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA, Newby TJ.
    Am J Vet Res; 1982 Dec 15; 43(12):2170-2. PubMed ID: 7165161
    [Abstract] [Full Text] [Related]

  • 3. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA, Newby TJ.
    Am J Vet Res; 1984 Apr 15; 45(4):695-7. PubMed ID: 6731981
    [Abstract] [Full Text] [Related]

  • 4. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL, Thomas GM.
    J Am Vet Med Assoc; 1983 Jul 01; 183(1):63-5. PubMed ID: 6874524
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD, Eckblad WP, Magonigle RA.
    Am J Vet Res; 1982 Aug 01; 43(8):1360-2. PubMed ID: 7103219
    [Abstract] [Full Text] [Related]

  • 7. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW, Magonigle RA, Eckblad WP, Frank FW.
    Proc Annu Meet U S Anim Health Assoc; 1976 Aug 01; (80):79-88. PubMed ID: 1078098
    [No Abstract] [Full Text] [Related]

  • 8. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL.
    Am J Vet Res; 1983 May 01; 44(5):882-3. PubMed ID: 6869997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD, Zaugg JL, Maas J.
    J Am Vet Med Assoc; 1987 Jan 15; 190(2):171-3. PubMed ID: 3818429
    [Abstract] [Full Text] [Related]

  • 12. Low levels of chlortetracycline for anaplasmosis.
    Richey EJ, Brock WE, Kliewer IO, Jones EW.
    Am J Vet Res; 1977 Feb 15; 38(2):171-2. PubMed ID: 557303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL.
    Res Vet Sci; 1972 Nov 15; 13(6):536-9. PubMed ID: 4648995
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of free-roaming mule deer as carriers of anaplasmosis in an area of Idaho where bovine anaplasmosis is enzootic.
    Renshaw HW, Vaughn HW, Magonigle RA, Davis WC, Stauber EH, Frank FW.
    J Am Vet Med Assoc; 1977 Feb 01; 170(3):334-9. PubMed ID: 833034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline.
    Rogers RJ, Dunster PJ.
    Aust Vet J; 1984 Sep 01; 61(9):306. PubMed ID: 6517790
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.